{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:18:00Z","timestamp":1790291880577,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of Korea (NRF) grant funded by the Ministry of Science and ICT","award":["NRF-17 2022R1C1C1005979"],"award-info":[{"award-number":["NRF-17 2022R1C1C1005979"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Endocrine dysfunctions are commonly associated with mitochondrial diseases. This study aimed to investigate clinical characteristics and outcomes of endocrine manifestations in patients with mitochondrial diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This study included 54 patients from 47 families with mitochondrial diseases who were genetically confirmed; 49 patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), four with Pearson syndrome, and one with Kearns\u2013Sayre syndrome (KSS). Clinical and endocrine findings were retrospectively reviewed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The median age at diagnosis was 18.5 years (range, 0.1\u2009\u2212\u200949 years). In 49 patients with MELAS, the mean height and weight standard deviation scores were \u2212\u20092.0\u2009\u00b1\u20091.3 and \u2212\u20092.6\u2009\u00b1\u20091.6, respectively, with 44.9% (<jats:italic>n<\/jats:italic>\u2009=\u200922) of the patients exhibiting short stature at diagnosis. Twenty-three (46.9%) patients with MELAS were diagnosed with diabetes mellitus (DM) at a median age of 26 years (range, 12\u2009\u2212\u200950 years). Interestingly, papillary thyroid cancer was observed in 10.2% of patients (<jats:italic>n<\/jats:italic>\u2009=\u20095) with MELAS at a mean age of 34.1\u2009\u00b1\u20096.9 years. One patient with MELAS and one with KSS exhibited hypoparathyroidism. Patients with Pearson syndrome and KSS exhibited more severe short stature. Adrenal insufficiency was noted in 50% of the patients with Pearson syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In 20% of patients with MELAS, endocrine dysfunctions including having a short stature, DM, and hypoparathyroidism preceded the onset of neurological manifestations. Papillary thyroid cancer occurred in 10% of patients with MELAS. Patients with Pearson syndrome and KSS showed profound growth retardation and multisystem dysfunctions, such as chronic kidney disease and neurological defects, which contributed to increased mortality.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03773-6","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T16:37:40Z","timestamp":1747499860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Endocrine manifestations and long-term outcomes of patients with mitochondrial diseases"],"prefix":"10.1186","volume":"20","author":[{"given":"Ja Hye","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soojin","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beom Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Wook","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1196-7826","authenticated-orcid":false,"given":"Jin-Ho","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"3773_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.mce.2013.06.004","volume":"379","author":"AM Schaefer","year":"2013","unstructured":"Schaefer AM, Walker M, Turnbull DM, Taylor RW. Endocrine disorders in mitochondrial disease. Mol Cell Endocrinol. 2013;379:2\u201311.","journal-title":"Mol Cell Endocrinol"},{"key":"3773_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00415-015-7884-3","volume":"263","author":"YS Ng","year":"2016","unstructured":"Ng YS, Turnbull DM. Mitochondrial disease: genetics and management. J Neurol. 2016;263:179\u201391.","journal-title":"J Neurol"},{"key":"3773_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2016.151","volume":"13","author":"J Chow","year":"2017","unstructured":"Chow J, Rahman J, Achermann JC, Dattani MT, Rahman S. Mitochondrial disease and endocrine dysfunction. Nat Rev Endocrinol. 2017;13:92\u2013104.","journal-title":"Nat Rev Endocrinol"},{"key":"3773_CR4","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/jxb\/erj151","volume":"57","author":"DC Logan","year":"2006","unstructured":"Logan DC. The mitochondrial compartment. J Exp Bot. 2006;57:1225\u201343.","journal-title":"J Exp Bot"},{"key":"3773_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1210\/js.2017-00434","volume":"2","author":"IS Al-Gadi","year":"2018","unstructured":"Al-Gadi IS, Haas RH, Falk MJ, Goldstein A, McCormack SE. Endocrine disorders in primary mitochondrial disease. J Endocr Soc. 2018;2:361\u201373.","journal-title":"J Endocr Soc"},{"key":"3773_CR6","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1080\/10409238.2021.1934812","volume":"56","author":"CV Pereira","year":"2021","unstructured":"Pereira CV, Gitschlag BL, Patel MR. Cellular mechanisms of MtDNA heteroplasmy dynamics. Crit Rev Biochem Mol Biol. 2021;56:510\u201325.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"3773_CR7","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.2337\/diabetes.53.2007.S103","volume":"53","author":"JA Maassen","year":"2004","unstructured":"Maassen JA, \u2018t Hart LM, van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS, et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes. 2004;53:S103\u20139.","journal-title":"Diabetes"},{"key":"3773_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.6065\/apem.2346096.048","volume":"28","author":"HA Korkmaz","year":"2023","unstructured":"Korkmaz HA, Ozkan B. Hypoparathyroidism in children and adolescents. Ann Pediatr Endocrinol Metab. 2023;28:159\u201367.","journal-title":"Ann Pediatr Endocrinol Metab"},{"key":"3773_CR9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13023-022-02538-9","volume":"17","author":"A Yoshimi","year":"2022","unstructured":"Yoshimi A, Ishikawa K, Niemeyer C, Gr\u00fcnert SC. Pearson syndrome: A multisystem mitochondrial disease with bone marrow failure. Orphanet J Rare Dis. 2022;17:379.","journal-title":"Orphanet J Rare Dis"},{"key":"3773_CR10","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.bbagen.2011.03.015","volume":"1820","author":"S Yatsuga","year":"2012","unstructured":"Yatsuga S, Povalko N, Nishioka J, Katayama K, Kakimoto N, Matsuishi T, et al. Melas: A nationwide prospective cohort study of 96 patients in Japan. Biochim Biophys Acta. 2012;1820:619\u201324.","journal-title":"Biochim Biophys Acta"},{"key":"3773_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1651-2227.2008.01148.x","volume":"98","author":"S Wolny","year":"2009","unstructured":"Wolny S, McFarland R, Chinnery P, Cheetham T. Abnormal growth in mitochondrial disease. Acta Paediatr. 2009;98:553\u20134.","journal-title":"Acta Paediatr"},{"key":"3773_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2265.1992.tb02289.x","volume":"37","author":"JN Harvey","year":"1992","unstructured":"Harvey JN, Barnett D. Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol (Oxf). 1992;37:97\u2013103.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3773_CR13","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.jpeds.2017.02.008","volume":"184","author":"C Ghaddhab","year":"2017","unstructured":"Ghaddhab C, Morin C, Brunel-Guitton C, Mitchell GA, Van Vliet G, Huot C. Premature ovarian failure in French Canadian Leigh syndrome. J Pediatr. 2017;184:227\u2013e91.","journal-title":"J Pediatr"},{"key":"3773_CR14","doi-asserted-by":"publisher","first-page":"1298569","DOI":"10.3389\/fneur.2023.1298569","volume":"14","author":"BC Cox","year":"2023","unstructured":"Cox BC, Pearson JY, Mandrekar J, Gavrilova RH. The clinical spectrum of MELAS and associated disorders across ages: A retrospective cohort study. Front Neurol. 2023;14:1298569.","journal-title":"Front Neurol"},{"key":"3773_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/978-3-319-95046-4_30","volume":"1085","author":"SH Tsang","year":"2018","unstructured":"Tsang SH, Aycinena ARP, Sharma T. Mitochondrial disorder: Kearns-Sayre syndrome. Adv Exp Med Biol. 2018;1085:161\u20132.","journal-title":"Adv Exp Med Biol"},{"key":"3773_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3345\/kjp.2018.61.5.135","volume":"61","author":"JH Kim","year":"2018","unstructured":"Kim JH, Yun S, Hwang SS, Shim JO, Chae HW, Lee YJ, et al. The 2017 Korean National growth charts for children and adolescents: development, improvement, and prospects. Korean J Pediatr. 2018;61:135\u201349.","journal-title":"Korean J Pediatr"},{"key":"3773_CR17","doi-asserted-by":"crossref","unstructured":"Son JS, Seo GH, Kim Y-M, Kim G-H, Jin HK, Bae J-S et al. Clinical and genetic features of four patients with Pearson syndrome: an observational study. Medicine. 2022;101:e28793.","DOI":"10.1097\/MD.0000000000028793"},{"key":"3773_CR18","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1460-6984.2011.00072.x","volume":"47","author":"JL Read","year":"2012","unstructured":"Read JL, Whittaker RG, Miller N, Clark S, Taylor R, McFarland R, et al. Prevalence and severity of voice and swallowing difficulties in mitochondrial disease. Int J Lang Commun Disord. 2012;47:106\u201311.","journal-title":"Int J Lang Commun Disord"},{"key":"3773_CR19","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/ana.24736","volume":"80","author":"YS Ng","year":"2016","unstructured":"Ng YS, Feeney C, Schaefer AM, Holmes CE, Hynd P, Alston CL, et al. Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination. Ann Neurol. 2016;80:686\u201392.","journal-title":"Ann Neurol"},{"key":"3773_CR20","doi-asserted-by":"crossref","unstructured":"Feeney CL, Lim AZ, Fagan E, Blain A, Bright A, Maddison J et al. A case-comparison study of pregnant women with mitochondrial disease\u2013 What to expect? BJOG: an international journal of obstetrics and gynaecology. 2019;126:1380\u20139.","DOI":"10.1111\/1471-0528.15667"},{"key":"3773_CR21","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s10545-012-9567-x","volume":"36","author":"MV Tavares","year":"2013","unstructured":"Tavares MV, Santos MJ, Domingues AP, Pratas J, Mendes C, Sim\u00f5es M, et al. Antenatal manifestations of mitochondrial disorders. J Inherit Metab Dis. 2013;36:805\u201311.","journal-title":"J Inherit Metab Dis"},{"key":"3773_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-2002-36742","volume":"33","author":"M Matsuzaki","year":"2002","unstructured":"Matsuzaki M, Izumi T, Shishikura K, Suzuki H, Hirayama Y. Hypothalamic growth hormone deficiency and supplementary GH therapy in two patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Neuropediatrics. 2002;33:271\u20133.","journal-title":"Neuropediatrics"},{"key":"3773_CR23","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00125-007-0779-9","volume":"50","author":"RG Whittaker","year":"2007","unstructured":"Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM. Prevalence and progression of diabetes in mitochondrial disease. Diabetologia. 2007;50:2085\u20139.","journal-title":"Diabetologia"},{"key":"3773_CR24","doi-asserted-by":"publisher","first-page":"107584","DOI":"10.1016\/j.jdiacomp.2020.107584","volume":"35","author":"RO Yeung","year":"2021","unstructured":"Yeung RO, Al Jundi M, Gubbi S, Bompu ME, Sirrs S, Tarnopolsky M, et al. Management of mitochondrial diabetes in the era of novel therapies. J Diabetes Complications. 2021;35:107584.","journal-title":"J Diabetes Complications"},{"key":"3773_CR25","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/S0002-9440(10)61132-7","volume":"160","author":"V M\u00e1ximo","year":"2002","unstructured":"M\u00e1ximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Sim\u00f5es M. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: A study with emphasis on H\u00fcrthle cell tumors. Am J Pathol. 2002;160:1857\u201365.","journal-title":"Am J Pathol"},{"key":"3773_CR26","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/sj.onc.1203537","volume":"19","author":"JJ Yeh","year":"2000","unstructured":"Yeh JJ, Lunetta KL, van Orsouw NJ, Moore FD, Mutter GL, Vijg J, et al. Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential MtDNA sequence variants in cases with thyroid tumours. Oncogene. 2000;19:2060\u20136.","journal-title":"Oncogene"},{"key":"3773_CR27","doi-asserted-by":"crossref","unstructured":"Hertweck KL, Dasgupta S. The landscape of mtDNA modifications in cancer: A Tale of two cities. Front Oncol. 2017;7:262.","DOI":"10.3389\/fonc.2017.00262"},{"key":"3773_CR28","first-page":"9982449","volume":"2022","author":"S Chen","year":"2022","unstructured":"Chen S, Bao X, Chen H, Jia M, Li W, Zhang L, et al. Thyroid cancer-associated mitochondrial DNA mutation G3842A promotes tumorigenicity via ROS-mediated ERK1\/2 activation. Oxid Med Cell Longev. 2022;2022:9982449.","journal-title":"Oxid Med Cell Longev"},{"key":"3773_CR29","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/sj.onc.1208292","volume":"24","author":"KK Abu-Amero","year":"2005","unstructured":"Abu-Amero KK, Alzahrani AS, Zou M, Shi Y. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines. Oncogene. 2005;24:1455\u201360.","journal-title":"Oncogene"},{"key":"3773_CR30","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1182\/blood-2003-07-2446","volume":"103","author":"N Gattermann","year":"2004","unstructured":"Gattermann N, Wulfert M, Junge B, Germing U, Haas R, Hofhaus G. Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome. Blood. 2004;103:1499\u2013502.","journal-title":"Blood"},{"key":"3773_CR31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/S0016-5085(00)70169-7","volume":"118","author":"W Habano","year":"2000","unstructured":"Habano W, Sugai T, Nakamura SI, Uesugi N, Yoshida T, Sasou S. Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology. 2000;118:835\u201341.","journal-title":"Gastroenterology"},{"key":"3773_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1567-7249(03)00106-5","volume":"3","author":"A Lorenc","year":"2003","unstructured":"Lorenc A, Bryk J, Golik P, Kupryja\u0144czyk J, Ostrowski J, Pronicki M, et al. Homoplasmic MELAS A3243G Mtdna mutation in a colon cancer sample. Mitochondrion. 2003;3:119\u201324.","journal-title":"Mitochondrion"},{"key":"3773_CR33","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/bjc.2015.66","volume":"112","author":"M Lund","year":"2015","unstructured":"Lund M, Melbye M, Diaz LJ, Duno M, Wohlfahrt J, Vissing J. Mitochondrial dysfunction and risk of cancer. Br J Cancer. 2015;112:1134\u201340.","journal-title":"Br J Cancer"},{"key":"3773_CR34","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.trecan.2022.08.001","volume":"8","author":"M Kim","year":"2022","unstructured":"Kim M, Mahmood M, Reznik E, Gammage PA. Mitochondrial DNA is a major source of driver mutations in cancer. Trends Cancer. 2022;8:1046\u201359.","journal-title":"Trends Cancer"},{"key":"3773_CR35","doi-asserted-by":"publisher","first-page":"149","DOI":"10.6065\/apem.2142150.075","volume":"26","author":"HW Yoo","year":"2021","unstructured":"Yoo HW. Diverse etiologies, diagnostic approach, and management of primary adrenal insufficiency in pediatric age. Ann Pediatr Endocrinol Metab. 2021;26:149\u201357.","journal-title":"Ann Pediatr Endocrinol Metab"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03773-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03773-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03773-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T16:37:43Z","timestamp":1747499863000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03773-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3773"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03773-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Asan Medical Center, Seoul, Korea (IRB No. 2024\u2009\u2212\u20090271).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed to publish the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no completing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"235"}}